Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
adults across BMI categories
A protocol page covers a single peptide compound: its dosing, reconstitution, mechanism, side effects, and clinical data
PMCID: PMC2645018
For the spending trends, the research team looked at total payments (from patients, insurance, employers, Medicare, Medicaid and other programs) and out-of-pocket payments made directly by patients and their families
Study participants We identified all adult (aged 20 years) patients with NAFLD and type 2 diabetes who had newly started treatment with non-insulin glucose-lowering drugs (metformin, GLP-1RAs, SGLT2 inhibitors, sulfonylureas, meglitinides, thiazolidinediones, acarbose or dipeptidyl peptidase-4 inhibitors) between 1 January 2013 and 31 December 2021
US$ 21.53
US$ 29.86
US$ 25.98
US$ 22.10
US$ 25.69
US$ 21.74
